top of page
1756399333-Photoroom.png

Longevity Industry Journal 2025

Science and Medicine, Financial Industry and Investments, Governance and National Healthcare Systems

Join Journal Waitlist

Longevity Industry Journal is designed to serve as the first dedicated industry journal for the exponentially expanding Global Longevity Industry, a series of journals updated and released every year.


This Journal presents up-to-date summaries, investment and sector-specific digests, key market trends and near-future forecasts of the full scope of Longevity Industry developments as they stand at the dawn of 2025, compressed into digestible and understandable summaries and chapters in order to distil only the most important take-aways required for investors, entrepreneurs, medical professionals and practitioners, policy makers, financial executives and other Longevity Industry professionals to optimise their decision making, effectively plan their near-future strategic agendas for the rest of 2025 and beyond, and obtain tangible and reliable state-of-the-market intelligence and digests on the continued, multifaceted evolution of the global megatrend of Longevity Industrialisation.


Even though the Longevity Industry has witnessed unprecedented levels of growth and maturation over the past decade, the term Longevity per se, and its fundamental definition, remains unclear to many people (and to investors in particular) who associate Longevity with such topics as typical anti-aging skin creams and the fitness and wellness industries. 


In reality, Longevity is the deepest of all DeepTech sectors, and occupies the forefront of advanced biomedicine, sitting at the intersection of many Tech and Frontier Technologies domains. The industry’s intersection with, and reliance upon, advanced technologies does not, however, exclude or preclude the fact that it is also deeply interconnected with specific behavioural and lifestyle interventions. What it does mean, however, is that the scope and sophistication of technology-based tools and methods of optimising day-to-day Healthy Longevity are large, rapidly increasing, and much broader (and deeper) than many people may realise, extending far beyond simplistic approaches involving diet, exercise, and supplements, encompassing DeepTech products and services that are becoming increasingly available to the consumer.


One of the central motivating factors for the production of the present state-of-the-market summary is precisely the prevalent challenge of disproportions in accepted Longevity Industry definitions and frameworks among different stakeholders. Scientists, medical practitioners, technologists, entrepreneurs, investors, financial executives and policy makers often have their own limited domain-specific understanding of the scope and breadth of what qualifies as Longevity Industry, despite the fact that cross-sector and trans-domain dialogue and cooperation is the most efficient means of translating the potential benefits of Longevity Industrialisation into real-world practical impacts on the health and wealth of citizens and national economies.


In the production of the present market summary, we have endeavoured to reflect a maximally objective and unbiased digest on the current state, main challenges and opportunities, and near-future of Longevity Industry within each of the respective subsectors and domains - Longevity Finance, Healthcare Innovations, NeuroTech, Wellness and Lifestyle, Agetech and AssistiveTech, AgeTech and AssistiveTech, Longevity Urbanism, Advanced Longevity R & D, and Advanced BioTech R & D - that are held by its major stakeholders and participants. Utilising as diverse, numerous and reputable sources of information as possible, we have made decisive efforts to assemble a market summary that is maximally factual and comprehensive, reflective of the overall consensus among each domain’s specific practitioners and professionals, and have avoided as much as possible what might be considered or construed as merely opinion. In this specific regard, we have exclusively relied upon our own internal research and analytics only in specific cases and sectors that are so new that no other group or entity has presented their own thoughts, analysis or forecasts on them until now. 


This explicit focus on factuality is perhaps more important for Longevity Industry than any other industry, given existing disparities between how different types of industry professionals define the full scope of sectors that it encompasses. In assembling the present market summary, we have taken an intentionally broad approach, including recent developments and major driving trends across every sector included in the Longevity Industry Framework used as the basis for constructing the high-level organisational structure of the present industry summary.

 

Longevity Industry Journal 2025 has been assembled and published by three leading professional organisations on the forefront of Longevity Industry developments: 

  • Deep Knowledge Group, a consortium of commercial and non-profit organisations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), whose venture arm made its first investment into the Longevity Industry in 2014. 

  • Aging Analytics Agency, the only market intelligence and industry analytics company dedicated exclusively to Longevity Industry, founded in 2013 and currently serving as an Official Member Organisation of the United Nations NGO Committee on Ageing and main source of market intelligence for Longevity.Capital.

  • Longevity.International, a first-of-its-kind, open-access non-profit decentralised Longevity Industry Knowledge and Collaboration Platform launched by more than 30 Longevity-focused co-founding non-profit members  from around the world.

Screenshot_3.jpg
Longevity Industry Journal 2025 One Pager.png

One Pager

Longevity Industry Journal 2025 Teaser.png

Teaser

Teaser

1. Global Longevity Industry Ecosystem (Chapter Overview)

This section outlines the current landscape of the global Longevity Industry, with key data on the vast network of companies, investors, and research hubs. It emphasizes the industry's complexity, which spans over 183,000 companies and more than 100,000 investors across 20 sectors. Despite rapid growth, the sector still faces a challenge: the definition of "longevity" remains too narrow for many stakeholders. The sector encompasses advanced biomedicine, technology, and behavioral sciences, and is increasingly viewed as a DeepTech domain. This chapter explores the essential role of technological advances in shaping longevity, from gene therapies to AI-driven health diagnostics, and emphasizes that the growth of the longevity economy is transforming the way we think about human health and wealth.

Screenshot_1.jpg

2. Ethics and Governance of Longevity (Chapter Overview)

As the longevity industry continues to evolve, there are growing calls for comprehensive ethical guidelines and governance frameworks to ensure that advances in healthspan and lifespan extension are accessible, inclusive, and beneficial to society as a whole. This section discusses the importance of transparency, inclusivity, and forward-thinking regulations that align the industry's progress with societal well-being. It also addresses the social and economic challenges posed by an aging population and the need for innovative policy responses to create a fairer and more sustainable future for all generations.

3. Advanced Longevity, BioTech, and NeuroTech (Chapter Overview)

Focusing on cutting-edge research and breakthroughs, this section dives into the intersections of longevity science, biotechnology, and neurotechnology. The advances in gene therapy, regenerative medicine, and AI-driven drug discovery are outlined, showcasing the potential for these technologies to delay aging and prevent age-related diseases. A critical focus is placed on therapies that target aging at the cellular level, including mitochondrial rejuvenation, stem cell therapies, and the development of age-related biomarkers. The integration of AI in this space is highlighted as a key enabler of faster, more efficient research.

Screenshot_7.jpg

4. Healthcare Innovations (Chapter Overview)

This chapter covers emerging healthcare innovations designed to tackle aging and its associated diseases. It explores how advances in personalized medicine, AI diagnostics, digital health platforms, and wearable technologies are revolutionizing patient care. Special attention is given to precision health, which tailors medical treatments to the individual based on genetics, environment, and lifestyle. Innovations in medical devices and telemedicine also play a pivotal role in expanding access to healthcare and improving outcomes for aging populations.

Screenshot_5.jpg

5. AgeTech and AssistiveTech (Chapter Overview)

The AgeTech and AssistiveTech sectors focus on innovations aimed at improving the quality of life for elderly individuals, supporting independence, and promoting better health outcomes. These technologies range from wearable health monitors and smart home systems to advanced mobility aids and cognitive support tools. The section explores the growing demand for solutions that enhance both physical and mental health for aging populations, as well as the impact of these technologies on caregivers and healthcare professionals.

Screenshot_10.jpg

6. Longevity Industry Investments (Chapter Overview)

This section examines the investment landscape of the longevity industry, tracking the capital flow into various subsectors such as longevity finance, biotech, AI healthcare, and wellness. The role of venture capital, private equity, and institutional investors in driving innovation and bringing new solutions to market is discussed in detail. It includes profiles of top investors, an overview of prominent longevity companies, and an analysis of recent IPOs in the sector. The section also explores the rise of longevity-focused financial instruments like ETFs and indices.

Screenshot_2.jpg

7. NeuroTech and Cognitive Enhancement (Chapter Overview)

Neurotechnology is positioned as a pivotal component of the longevity industry, with a focus on mental health, neuromedicine, and cognitive augmentation. This chapter discusses how AI-powered solutions, such as virtual therapists and wearables, are transforming mental health care, particularly in addressing the growing global mental health crisis. The use of AI in early diagnosis of neurodegenerative diseases, such as Alzheimer's and Parkinson’s, and the potential for brain-computer interfaces to restore lost functions, are also explored.

8. Longevity Urbanism (Chapter Overview)

Longevity Urbanism represents a visionary approach to designing urban spaces and infrastructure to promote health and vitality for all age groups. This section highlights the growing importance of age-friendly cities and smart communities that prioritize the needs of the elderly, from accessible housing and transportation to social connectivity and healthcare facilities. The chapter outlines the evolving concept of “longevity valleys,” which integrate living spaces, wellness facilities, and healthcare services to support long-term health and well-being.

Screenshot_12.jpg

9. Longevity Finance (Chapter Overview)

This section delves into the emerging field of longevity finance, where financial products and services are evolving to address the challenges and opportunities created by an aging population. Topics covered include longevity insurance, wealth management for long-lived individuals, and the role of financial institutions in adapting to the longevity economy. The chapter also explores innovative financial solutions for funding longevity-related research and supporting the commercialization of longevity technologies.

Screenshot_13.jpg

10. Challenges and Opportunities in Longevity Governance

Longevity governance addresses the policy and regulatory frameworks necessary to manage the impact of a longer life expectancy on social systems, economies, and healthcare. This section emphasizes the need for governments to proactively prepare for demographic shifts, ensure equitable access to longevity innovations, and address the ethical concerns associated with life-extension technologies. It includes discussions on the governance of biotechnology, gene editing, and emerging healthcare models.

Download the Full Journal

Download

Explore in-depth insights, case studies, and expert analysis from leading innovators in the burgeoning multi-sector Longevity Industry

Global Longevity Ecosystem

longevity industry 1.0
Longevity Industry 1.0

Defining the Biggest and Most Complex Industry in Human History

dashboard
Big Data Analytical Dashboards

Navigate Complex Longevity Industry with ease. Your Key to VC, PE and M&A for Longevity related Industries

longevity international
Longevity International Platform

A first-of-its-kind, open-access non-profit decentralized Longevity Industry Knowledge and Collaboration platform

Production Counterparties

deep knowledge group

Deep Knowledge Group is a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, media, philanthropy and more.

2025-08-22_16-46.png

Longevity Industry Analytics is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health, and their impact on healthcare industry. 

Longevity International

Longevity.International is a first-of-its-kind, open-access non-profit decentralized Longevity Industry Knowledge and Collaboration platform with the aim of promoting a greater degree of synergy, efficient cooperation, and discussion among a variety of Longevity Industry participants and stakeholders.

Full Video

Video
bottom of page